Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction

Cardiology Section, Department of Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, NC, USA.
Circulation Heart Failure (Impact Factor: 5.89). 07/2010; 3(4):477-85. DOI: 10.1161/CIRCHEARTFAILURE.109.898916
Source: PubMed


Exercise intolerance is the primary symptom in older patients with heart failure and preserved ejection fraction (HFPEF); however, little is known regarding its mechanisms and therapy.
Seventy-one stable elderly (70+/-1 years) patients (80% women) with compensated HFPEF and controlled blood pressure were randomized into a 12-month follow-up double-blind trial of enalapril 20 mg/d versus placebo. Assessments were peak exercise oxygen consumption; 6-minute walk test; Minnesota Living with HF Questionnaire; MRI; Doppler echocardiography; and vascular ultrasound. Compliance by pill count was excellent (94%). Twenty-five patients in the enalapril group versus 34 in the placebo group completed the 12-month follow-up. During follow-up, there was no difference in the primary outcome of peak exercise oxygen consumption (enalapril, 14.5+/-3.2 mL/kg/min; placebo, 14.3+/-3.4 mL/kg/min; P=0.99), or in 6-minute walk distance, aortic distensibility (the primary mechanistic outcome), left ventricle mass, or neurohormonal profile. The effect size of enalapril on peak exercise oxygen consumption was small (0.7%; 95% CI, 4.2% to 5.6%). There was a trend toward improved Minnesota Living with HF Questionnaire total score (P=0.07), a modest reduction in systolic blood pressure at peak exercise (P=0.02), and a marginal improvement in carotid arterial distensibility (P=0.04).
In stable, older patients with compensated HFPEF and controlled blood pressure, 12 months of enalapril did not improve exercise capacity or aortic distensibility. These data, combined with those from large clinical event trials, suggest that angiotensin inhibition does not substantially improve key long-term clinical outcomes in this group of patients. This finding contrasts sharply with observations in HF with reduced EF and highlights our incomplete understanding of this important and common disorder.

Download full-text


Available from: William C Little, Dec 15, 2014
  • Source
    • "Intact cardiomyocytes are increasingly being used to investigate the molecular mechanisms of cardiomyocyte contractility and to screen therapeutic compounds that could be used to treat cardiac diseases (King et al. 2011; Malik and Morgan 2011; Aronson and Krum 2012; Campbell et al. 2013). New compounds could help millions of patients by changing calcium transients or cross-bridge function (Massie et al. 2008; Kitzman et al. 2010; Borlaug and Paulus 2011; Zile et al. 2011; Steinberg et al. 2012). However, the effects of some experimental factors that may influence cardiomyocyte function have not yet been quantified. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Intact cardiomyocytes are increasingly being used to investigate the molecular mechanisms of contraction and to screen new therapeutic compounds. The function of the cardiomyocytes is often measured from the calcium transients and sarcomere length profiles. We studied the role of experimental temperature and transmural region on indices of function in freshly isolated, unloaded cardiomyocytes. Intact cardiomyocytes were isolated from the subendocardium, midmyocardium, and subepicardium of 3-month-old Sprague-Dawley rats. Myocytes from each region were studied at 25°C, 31°C, and 37°C. Cytosolic calcium transients were measured using Fura-2 fluorescence, whereas sarcomere length shortening and relengthening profiles were measured using high-speed video capture. For both the calcium transients and sarcomere length profiles, the time to peak and the time to half relaxation decreased significantly with increasing temperature. Increasing temperature also raised the minimum and maximum calcium levels of all cells. Of note, there was a reduced coefficient of variation (standard deviation divided by the mean) at higher temperatures for calcium fluorescence amplitudes, time to peak calcium, and rates of sarcomeric shortening and relengthening. The amplitudes and minimum of the calcium transients were significantly dependent on transmural region, and several sarcomere length parameters exhibited statistical interactions between temperature and transmural region. Together, these results show that biological variability can be reduced by performing experiments at 37°C rather than at room temperature, and by isolating cells from a specific transmural region. Adopting these procedures will improve the statistical power of subsequent analyses and increase the efficiency of future experiments.
    Full-text · Article · Nov 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ceramic capacitors failed insulation resistance at less than 1/10 th their rated voltage despite the fact that they had been subjected to "voltage conditioning" at twice the rated voltage for 100 h. Many failures recovered as the voltage was increased. Using special sectioning procedures, the failures were isolated to single ceramic plates; however, extensive analysis did not initially determine the cause of failure. Finally, the ceramic was ground from all four sides and an unexpected discovery was made: the plates could be peeled apart intact. This allowed dissection of the capacitor structure, completely exposing the shorted plates. Using the absorbed-current mode of the SEM, it was determined that the only leakage was through very small voids in the ceramic. Peeling the plates apart also provided the ability to see delaminations and other defects in three dimensions and to examine the electrodes and plate surfaces in minute detail. Based on this and related experiences, it is concluded that ceramic capacitors that fail at low voltage and recover or partially recover as the voltage is increased are fairly prevalent. Screening results indicate the need for special screening for ceramic capacitors intended for low-voltage applications.
    No preview · Article · Feb 1979 · IEEE Transactions on Electron Devices
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Different from heart failure with reduced ejection fraction (HFREF), for which large studies have demonstrated the effectiveness of drug treatment to improve morbidity and mortality, no treatment study has shown definitive results in patients with heart failure with normal ejection fraction (HFNEF). HFNEF is more prevalent in women and the elderly and it is associated with multiple comorbidities. Although the optimum treatment has yet to be defined, the control of arterial hypertension and decreased fluid overload are important measures to control the syndrome. In Brazil, the recommendations for the treatment of HF are based on the Review of the II Directives of the Brazilian Society of Cardiology for the diagnosis and treatment of Heart Failure - 2002. However, none of the recommendations is specific for patients with HFNEF, as they are based on general measures proposed by specialists. This review aims at demonstrating the scientific evidence from recent clinical trials in HFNEF and future perspectives in terms of new medications.
    Preview · Article · Mar 2010 · Arquivos brasileiros de cardiologia
Show more